Traws Pharma, Inc. (TRAW) Q2 2024 Earnings
TRAW·Reported November 14, 2024·Before market open
Traws Pharma, Inc. reported Q2 2024 revenue of $56.0K, missed analyst consensus of $60.0K by $4.0K. Diluted EPS came in at $-8.81, missed the $-6.25 consensus by $2.56.
Revenue
$56.0Kmissed by $4.0K
Consensus: $60.0KDiluted EPS
$-8.81missed by $2.56
Consensus: $-6.25
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Traws Pharma, Inc.'s Q2 2024 earnings report.
Traws Pharma, Inc. (TRAW) reported Q2 2024 earnings on November 14, 2024 before market open.
Traws Pharma, Inc. reported revenue of $56.0K and diluted EPS of $-8.81 for Q2 2024.
Revenue missed the consensus estimate of $60.0K by $4.0K. EPS missed the consensus estimate of $-6.25 by $2.56.
You can read the 10-Q periodic report (0001558370-24-012279) directly on SEC EDGAR. The filing index links above go to sec.gov.